IA
AMAG

Icon Advisers’s AMAG Pharmaceuticals AMAG Stock Holding History

Icon Advisers’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-39,100
Closed -$958K – 462
2016
Q3 		$958K Buy
+39,100
New +$977K 0.06% 304
2015
Q4 		– Sell
-9,512
Closed -$378K – 381
2015
Q3 		$378K Buy
+9,512
New +$590K 0.03% 312

Other funds holding AMAG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Icon Advisers's AMAG Position: Q4 2016 in Review

Icon Advisers sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 39,100 shares — an estimated $958K sold.

Icon Advisers first reported a position in AMAG in Q3 2015 and held it in 2 quarters. The position peaked at $958K in Q3 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • Icon Advisers reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Icon Advisers sold 39,100 AMAG Pharmaceuticals shares in Q4 2016, an estimated $958K.
  • Icon Advisers first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Icon Advisers's AMAG Pharmaceuticals position peaked at $958K in Q3 2016.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Icon Advisers's 13F filing for Q4 2016, filed 1 Feb 2017.